VolitionRx Limited
VNRX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.16 | -0.57 | -0.46 |
| FCF Yield | -50.98% | -37.49% | -12.53% | -13.20% |
| EV / EBITDA | -2.13 | -1.06 | -4.40 | -5.79 |
| Quality | ||||
| ROIC | -987.22% | -175.88% | -1,401.95% | -128.83% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.95 | 0.51 | 0.50 | 0.77 |
| Growth | ||||
| Revenue 3-Year CAGR | 59.08% | 104.97% | 183.60% | 73.98% |
| Free Cash Flow Growth | -38.23% | -13.64% | 22.81% | -18.59% |
| Safety | ||||
| Net Debt / EBITDA | -0.10 | 0.44 | 0.20 | 0.64 |
| Interest Coverage | -79.40 | -162.38 | -183.61 | -181.85 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 32.72 | 114.22 | 86.50 | 50.72 |